Continuous glucose monitoring in early gestational diabetes improves maternal and neonatal outcomes-The Steady Sugar trial.

ABSTRACT:

Aims

Early detection and management of gestational diabetes mellitus (GDM) benefits both mother and infants. We aimed to compare continuous glucose monitoring (CGM) to routine self-monitoring of blood glucose (SMBG) in a randomised controlled trial on glycaemic management and pregnancy outcomes in women with GDM diagnosed in gestational Weeks 8-26.

Materials and methods

From October 2021 to December 2023, 128 women with GDM were enrolled and 120 completed the trial after 2:1 randomisation to either the intervention (Dexcom G6 CGM, n = 80) or the control group (SMBG 4×/day and monthly blinded CGM [Dexcom G6 Pro], n = 40). Both groups received lifestyle and medication advice based on the CGM interpretation, clinical follow-up and glucose monitoring until delivery. CGM metrics

SUBMITTER: Elkind-Hirsch K 

PROVIDER: S-EPMC12673445 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature